Latest news
Minerva Neurosciences Provides Second Quarter 2026 Financial Results and Business Updates - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 12:48:05 GMTFDA Clears Bria-PROS+ Immunotherapy Trial in Prostate Cancer - Targeted OncologyTargeted Oncology · Fri, 07 Aug 2026 00:45:35 GMTBriaCell Therapeutics Corp. (BCTXL) Stock Price, News, Quote & History - Yahoo! Finance CanadaYahoo! Finance Canada · Thu, 06 Aug 2026 06:40:47 GMTBriaCell Receives FDA Clearance to Initiate Bria-PROS+ Clinical Study in Prostate Cancer - Investing News NetworkInvesting News Network · Wed, 05 Aug 2026 12:47:14 GMTBriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:30:00 GMTFDA clearance lets BriaCell test personalized prostate immunotherapy - Stock TitanStock Titan · Wed, 05 Aug 2026 11:30:00 GMT